Central Trust Company’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $46.5M | Buy |
213,747
+1,153
| +0.5% | +$256K | 0.92% | 27 |
|
|
2025
Q4 | $48.6M | Sell |
212,594
-3,755
| -2% | -$855K | 0.95% | 26 |
|
|
2025
Q3 | $50.1M | Sell |
216,349
-1,989
| -0.9% | -$405K | 1.05% | 24 |
|
|
2025
Q2 | $40.5M | Sell |
218,338
-11,458
| -5% | -$2.13M | 0.94% | 26 |
|
|
2025
Q1 | $48.1M | Sell |
229,796
-2,634
| -1% | -$512K | 1.18% | 18 |
|
|
2024
Q4 | $41.3M | Buy |
232,430
+3,105
| +1% | +$571K | 1.01% | 23 |
|
|
2024
Q3 | $45.3M | Sell |
229,325
-4,709
| -2% | -$879K | 1.06% | 21 |
|
|
2024
Q2 | $40.1M | Sell |
234,034
-5,766
| -2% | -$955K | 0.98% | 25 |
|
|
2024
Q1 | $43.7M | Sell |
239,800
-8,229
| -3% | -$1.42M | 1.09% | 23 |
|
|
2023
Q4 | $38.4M | Sell |
248,029
-1,978
| -0.8% | -$288K | 1.02% | 23 |
|
|
2023
Q3 | $37.3M | Sell |
250,007
-3,271
| -1% | -$480K | 1.07% | 20 |
|
|
2023
Q2 | $34.1M | Sell |
253,278
-4,849
| -2% | -$711K | 0.95% | 24 |
|
|
2023
Q1 | $41.1M | Sell |
258,127
-2,071
| -0.8% | -$317K | 1.2% | 16 |
|
|
2022
Q4 | $42.1M | Sell |
260,198
-8,126
| -3% | -$1.25M | 1.3% | 14 |
|
|
2022
Q3 | $36M | Buy |
268,324
+11,896
| +5% | +$1.71M | 1.23% | 17 |
|
|
2022
Q2 | $39.3M | Sell |
256,428
-5,870
| -2% | -$897K | 1.3% | 16 |
|
|
2022
Q1 | $42.5M | Sell |
262,298
-1,864
| -0.7% | -$271K | 1.22% | 18 |
|
|
2021
Q4 | $35.8M | Buy |
264,162
+794
| +0.3% | +$93.8K | 1.01% | 20 |
|
|
2021
Q3 | $28.4M | Buy |
263,368
+5,019
| +2% | +$573K | 1.01% | 22 |
|
|
2021
Q2 | $29.1M | Buy |
258,349
+3,989
| +2% | +$449K | 1.06% | 19 |
|
|
2021
Q1 | $27.5M | Buy |
254,360
+3,578
| +1% | +$383K | 1.08% | 21 |
|
|
2020
Q4 | $26.9M | Buy |
250,782
+4,902
| +2% | +$471K | 1.1% | 20 |
|
|
2020
Q3 | $21.5M | Buy |
245,880
+6,563
| +3% | +$618K | 0.97% | 21 |
|
|
2020
Q2 | $23.5M | Buy |
239,317
+13,795
| +6% | +$1.21M | 1.18% | 15 |
|
|
2020
Q1 | $17.2M | Buy |
225,522
+8,310
| +4% | +$708K | 1.05% | 21 |
|
|
2019
Q4 | $19.2M | Buy |
217,212
+19,769
| +10% | +$1.64M | 0.98% | 26 |
|
|
2019
Q3 | $15M | Buy |
197,443
+3,178
| +2% | +$218K | 0.84% | 30 |
|
|
2019
Q2 | $13.8M | Buy |
194,265
+2,608
| +1% | +$205K | 0.79% | 33 |
|
|
2019
Q1 | $15.4M | Sell |
191,657
-20,513
| -10% | -$1.68M | 0.92% | 27 |
|
|
2018
Q4 | $19.6M | Sell |
212,170
-6,387
| -3% | -$562K | 1.3% | 20 |
|
|
2018
Q3 | $20.7M | Sell |
218,557
-36,707
| -14% | -$3.48M | 1.2% | 19 |
|
|
2018
Q2 | $23.7M | Buy |
255,264
+316
| +0.1% | +$30.9K | 1.51% | 11 |
|
|
2018
Q1 | $24.1M | Sell |
254,948
-2,189
| -0.9% | -$240K | 1.53% | 9 |
|
|
2017
Q4 | $24.9M | Sell |
257,137
-5,821
| -2% | -$549K | 1.51% | 11 |
|
|
2017
Q3 | $23.4M | Buy |
262,958
+2,911
| +1% | +$222K | 1.51% | 9 |
|
|
2017
Q2 | $18.9M | Sell |
260,047
-476
| -0.2% | -$32K | 1.25% | 18 |
|
|
2017
Q1 | $17M | Buy |
260,523
+19,898
| +8% | +$1.25M | 1.13% | 20 |
|
|
2016
Q4 | $15.1M | Buy |
240,625
+278
| +0.1% | +$17K | 1.04% | 22 |
|
|
2016
Q3 | $15.2M | Buy |
240,347
+6,383
| +3% | +$413K | 1.11% | 20 |
|
|
2016
Q2 | $14.5M | Sell |
233,964
-2
| -0% | -$122 | 1.08% | 21 |
|
|
2016
Q1 | $13.4M | Buy |
233,966
+30,762
| +15% | +$1.71M | 1.05% | 21 |
|
|
2015
Q4 | $12M | Sell |
203,204
-8,312
| -4% | -$479K | 0.99% | 22 |
|
|
2015
Q3 | $11.5M | Sell |
211,516
-4,128
| -2% | -$269K | 1% | 19 |
|
|
2015
Q2 | $14.5M | Buy |
215,644
+3,424
| +2% | +$224K | 1.14% | 16 |
|
|
2015
Q1 | $12.4M | Buy |
212,220
+8,405
| +4% | +$508K | 1% | 20 |
|
|
2014
Q4 | $13.3M | Sell |
203,815
-4,081
| -2% | -$257K | 1.09% | 19 |
|
|
2014
Q3 | $12M | Buy |
207,896
+1,022
| +0.5% | +$56.7K | 0.95% | 23 |
|
|
2014
Q2 | $11.7M | Sell |
206,874
-644
| -0.3% | -$33.8K | 0.92% | 22 |
|
|
2014
Q1 | $10.7M | Sell |
207,518
-1,391
| -0.7% | -$70.3K | 0.88% | 23 |
|
|
2013
Q4 | $11M | Sell |
208,909
-28,227
| -12% | -$1.39M | 0.93% | 23 |
|
|
2013
Q3 | $10.6M | Sell |
237,136
-1,168
| -0.5% | -$51.8K | 0.96% | 23 |
|
|
2013
Q2 | $9.85M | Buy |
+238,304
| New | +$10.4M | 0.94% | 25 |
|
Other funds holding ABBV
VCM
VPM
Central Trust Company's ABBV Position: Q1 2026 in Review
Central Trust Company increased its AbbVie (ABBV) stake by 0.54% in Q1 2026, buying an estimated $256K and bringing the position to 213,747 shares worth $46.5M. The position accounts for 0.92% of the portfolio, ranked #27.
Central Trust Company first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $50.1M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Central Trust Company held 213,747 shares of AbbVie worth $46.5M as of Q1 2026.
- Central Trust Company bought 1,153 AbbVie shares in Q1 2026, an estimated $256K.
- AbbVie made up 0.92% of Central Trust Company's portfolio in Q1 2026, its #27 holding.
- Central Trust Company first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Central Trust Company's AbbVie position peaked at $50.1M in Q3 2025.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.